FDA
-
-
-
-
-
-
-
Prometic Reports Third Quarter 2018 Financial Results and Highlights
-
-
-
-
-
-
-
Prometic reports on its 2018 annual and special meeting of shareholders highlights
-
-
-
-
-
-
-
Prometic Announces Publication of PBI-4050's Novel Antifibrotic Mechanism of Action in American Journal of Pathology
-
-
-
-
-
-
-
For the First Time Ever, There Will be a Full Week Dedicated to Plasminogen Deficiency (PLGD) !
-
-
-
-
-
-
-
Prometic Presents New Data on PBI-4050 and Plasminogen at the American Thoracic Society's 2017 International Conference
-
-
324,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

